Brind.

Sabra Healthcare REIT Raises 2026 Guidance Following Strong Q3 Results

1 report, 1 independent Updated Nov 3
AI-generated briefing. Brind wrote this from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Sabra Healthcare REIT reported normalized funds from operations of $0.39 per share and normalized adjusted funds from operations of $0.41 per share for the third quarter of 2026, which was an 8% increase from the prior year. The company raised the midpoint of its 2026 normalized FFO and normalized AFFO guidance by $0.005 per share.

From dailypolitical.com

Why it matters

Some supportBrind's analysis of the reports

The company reported strong performance in its senior housing portfolio, with same-store revenue growing 9.3% year-over-year and cash NOI growing 14.6%. This growth supports the updated outlook, which implies year-over-year per-share growth of 7% in normalized FFO and 8% in normalized AFFO.

From dailypolitical.com

Who's involved

  • Michael CostaChief Financial Officer of Sabra Healthcare REIT
  • SabraThe company reporting the financial results
  • Darrin SmithChief Investment Officer of Sabra Healthcare REIT

Who could feel it

Possible knock-on effects

These are possibilities Brind reasoned out, not predictions, and not advice. Most are not stated in any report.

  • SabraSpeculative

    The company might see increased investment or demand due to the higher guidance and strong operating margins.

Keep exploring

The entities involved

Coverage

Newest first; wire copies grouped